Previous 10 | Next 10 |
Search all stock news releases related news releases and press releases from US and Canada Markets.
Data generated by Adaptive’s next-generation sequencing-based MRD assay will support the development and commercialization of investigational medicines for hematologic malignancies SEATTLE, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a c...
Basement-Hosted Mineralization of 6.5 metres at 0.73% eU 3 O 8 ; Including 1.8 metres at 1.91% eU 3 O 8 Step Out Drilling Intersects Alteration and Fault Structures Above Unconformity 800 Metres Northeast of Pike Zone Vancouver, British Columbia--(Newsfile Corp. - November 7, ...
BRENTWOOD, Tenn., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading operator of surgical facilities, today announced financial results for the third quarter ended September 30, 2023. Revenues were $674.1 ...
Toronto, Ontario--(Newsfile Corp. - November 7, 2023) - Caprock Mining Corp. (CSE:CAPR) (" Caprock " or the " Company ") is pleased to announce the results of a high-resolution, drone-based magnetics survey that was recently completed at its Ackley Lithium-Tin-Molybdenum-REEs property (" Ackley "...
Received $6.6 million in cash receipts during the quarter related to our growing royalty base and certain development milestones One New Drug Application (NDA) was filed in the third quarter; another is anticipated prior to year-end Company anticipates the initiation of multiple...
Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Tuesday, November 14, 2023 to report its t...
35-subject SWING Trial evaluates the safety, performance of Surmodics’ Sundance™ Sirolimus Drug-Coated Balloon Updated safety and performance data for the SWING trial 24-month data will be shared Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device a...
Dr. Peter A. Schneider to share trial results during a Nov. 15 session Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that 36-month data from its TRANSCEND clinical trial will be prese...
Toronto, ON, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Plato Gold Corp. (TSX-V: PGC ) (OTCQB: NIOVF ) (Frankfurt: 4Y7 or WKN: A0M2QX ) (“ Plato ” or the “ Company ”) is pleased to announce that it has commenced a drill program on Marriott Gold Property,...
BURLINGTON, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today reported business updates and financial results for the third qu...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
14.71%Change Percent:
Bone Biologics Corp Company Name:
BBLG Stock Symbol:
NASDAQ Market:
bonebiologics.com Website: